Floatz logo

txa127

Myelofibrosis

Tarix PharmaceuticalsPhase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

48 Active assets in the Myelofibrosis cohort.

Asset / SponsorPhaseRating
Busulphan
City of Hope Medical Center
Phase 2B
CYCLOSPORIN A
City of Hope Medical Center
Phase 2B
Cyclophosphamide
City of Hope Medical Center
Phase 3B
Monomethyl Fumarate
Center for International Blood and Marrow Transplant Research
Phase 3B
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2/3B

View all 50 →

Same molecule, other indications

txa127 is also rated in:

Double Cord Blood TransplantDormant
CC
Indicative ·
43 / 100
View asset →
Chronic Myelocytic LeukemiaDormant
CC
Indicative ·
43 / 100
View asset →
Non Hodgkins LymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →